Search Results - "Giannone, Michael"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2

    Systemic inflammation is a determinant of outcomes of CD40 agonist-based therapy in pancreatic cancer patients by Wattenberg, Max M, Herrera, Veronica M, Giannone, Michael A, Gladney, Whitney L, Carpenter, Erica L, Beatty, Gregory L

    Published in JCI insight (08-03-2021)
    “…Agonistic anti-CD40 monoclonal antibody (mAb) therapy in combination with chemotherapy (chemoimmunotherapy) shows promise for the treatment of pancreatic…”
    Get full text
    Journal Article
  3. 3

    TNF blockade uncouples toxicity from antitumor efficacy induced with CD40 chemoimmunotherapy by Stone, Meredith L, Lee, Jesse, Herrera, Veronica M, Graham, Kathleen, Lee, Jae W, Huffman, Austin, Coho, Heather, Tooker, Evan, Myers, Max I, Giannone, Michael, Li, Yan, Buckingham, Thomas H, Long, Kristen B, Beatty, Gregory L

    Published in JCI insight (22-07-2021)
    “…Agonist CD40 antibodies are under clinical development in combination with chemotherapy as an approach to prime for antitumor T cell immunity. However,…”
    Get full text
    Journal Article
  4. 4

    Driver Response Time in Cut-Off Scenarios from the Second Strategic Highway Research Program Naturalistic Database by Dinakar, Swaroop, Muttart, Jeffrey W., Edewaard, Darlene E., Giannone, Michael, Dickson, Connor

    Published in Transportation research record (01-02-2022)
    “…A cut-in or cut-off scenario involves a vehicle intruding into the path of another vehicle traveling in the same direction. These lane changes can lead to…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8